Pharmacogenomics in Renal Transplantation: Tailoring Tacrolimus for Enhanced Patient Outcomes

被引:0
|
作者
Mishra, Vikash Chandra [1 ]
Raina, Vimarsh [1 ]
机构
[1] Chimera Transplant Res Fdn, Dept Mol Genet & Transplant Immunol, South Extens Part 2, New Delhi, India
关键词
D O I
10.4103/ijot.ijot_50_24
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:119 / 120
页数:2
相关论文
共 50 条
  • [31] Interactive Impact of Tacrolimus Inter-Patient Variability and Intra-Patient Variability in Allograft Outcomes in Kidney Transplantation
    Park, Yohan
    Lee, Hanbi
    Eum, Sang Hun
    Yoon, Se-Hee
    Hwang, Won Min
    Yun, Sung-Ro
    Yang, Chul Woo
    Chung, Byung Ha
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 537 - 537
  • [32] Renal Pathologies and Patient Outcomes Post Allogeneic Stem Cell Transplantation
    Ratanasrimetha, Praveen
    Mamlouk, Omar
    Tchakarov, Amanda
    Abudayyeh, Ala
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 638 - 638
  • [33] OUTCOMES WITH ALEMTUZUMAB INDUCTION AND TACROLIMUS OR TACROLIMUS AND MYCOPHENOLATE MOFETIL IN PEDIATRIC KIDNEY TRANSPLANTATION
    Nguyen, Christina R.
    Shapiro, Ron
    PEDIATRIC TRANSPLANTATION, 2013, 17 : 56 - 56
  • [34] Early Calculation of the Tacrolimus Concentration-to-Dose Ratio Does Not Predict Outcomes after Renal Transplantation
    Schuette-Nuetgen, K.
    Bartmann, I.
    Suwelack, B.
    Reuter, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 917 - 917
  • [35] The cost effectiveness of tacrolimus versus microemulsified cyclosporinA 10-year model of renal transplantation outcomes
    Michelle E. Orme
    Wieslaw A. Jurewicz
    Nagappan Kumar
    Tracy L. McKechnie
    PharmacoEconomics, 2003, 21 : 1263 - 1276
  • [36] Antibody preconditioning with tacrolimus monotherapy in pediatric renal transplantation
    Shapiro, R
    Ellis, D
    Tan, HP
    Moritz, ML
    Basu, A
    Vats, AN
    Khan, AS
    Gray, EJ
    Marcos, A
    Starzl, TE
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 547 - 548
  • [37] The cost effectiveness of tacrolimus versus microemulsified cyclosporin - A 10-year model of renal transplantation outcomes
    Orme, ME
    Jurewicz, WA
    Kumar, N
    McKechnie, TL
    PHARMACOECONOMICS, 2003, 21 (17) : 1263 - 1276
  • [38] Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study
    Nafar, Mohsen
    Keshtkari, Sara
    Ziaie, Shadi
    Firouzan, Ahmad
    Borumandnia, Nasrin
    Dalili, Nooshin
    Poorrezagholi, Fatemeh
    Samadian, Fariba
    Samavat, Shiva
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (03) : 187 - 194
  • [39] Tacrolimus in pediatric renal transplantation - Induction and conversion experience
    Ohta, T
    Kawaguchi, H
    Hattori, M
    Nagahuchi, H
    Takahashi, K
    Konomoto, T
    Akioka, Y
    Shiraga, H
    Ito, K
    Ishikawa, N
    Tanabe, K
    Fuchinoue, S
    Toma, H
    Takahashi, K
    JAPANESE JOURNAL OF TRANSPLANTATION, 1998, 33 (02) : 96 - 105
  • [40] Pharmacokinetics of tacrolimus in renal transplantation recipients during adolescence
    Vrieling-Prince, Femke
    Cornelissen, Marlies
    Bouts, Antonia H. M.
    van der Wouden, Romy Fleur
    Cransberg, Karlien
    Roodnat, Joke I.
    PEDIATRIC TRANSPLANTATION, 2022, 26